Allergan in Tight Spot for Blockbuster Drug Restasis
FIGHTS 2 PATENT BATTLES; NO SUB BLOCKBUSTER IN WINGS
Monday, October 30, 2017
Share this article:
A recent federal district court ruling—a federal judge invalidated exclusive protections for dry-eye drug Restasis—isn’t sitting well with Allergan PLC...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to OCBJ.com archives
- Book of Lists — the most comprehensive business resource in Orange County
- NEW: Orange County 500 — influential business leaders you need to know
For reprint and licensing requests for this article, Contact Kim Lopez